<http://webisa.webdatacommons.org/296830574>	<http://www.w3.org/ns/prov#value>	" response to treatment information of all reported cases of levamisole-induced cutaneous vasculitisLevamisole was an FDA-approved drug but was withdrawn for use in humans in the USA in 1999 due to reports of serious adverse effects such as agranulocytosis, thrombocytopenia, arthritis, and LIV" .
<http://webisa.webdatacommons.org/296830574>	<http://www.w3.org/ns/prov#wasQuotedFrom>	<pubmedcentralcanada.ca> .
<http://webisa.webdatacommons.org/296830574>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://www.w3.org/ns/prov#Entity> .
<http://webisa.webdatacommons.org/prov/215068774>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/296830574> .